• Aeshah I AlSagheir, Norah A Alrowais, Basema Kh Alkhudhair, Nada A AlYousefi, Ahmed I Al Sagheir, Asma M Ali, and Amel AlMakoshi.
• Ministry of Health, Riyadh, Kingdom of Saudi Arabia. E-mail. ayshah2000@gmail.com.
• Saudi Med J. 2020 May 1; 41 (5): 499507499-507.

ObjectivesTo evaluate the effect of decision aids (DAs) for metastatic colorectal cancer (mCRC) patients in the Arabic language.MethodsA multi-centered randomized control trial was used to evaluate the effect of Arabic DA use with usual care for mCRC patients compared to usual care alone. Patients were recruited from 4 main oncology centers in Saudi Arabia: King Fahad Medical City, Riyadh; King Khalid University Hospital, Riyadh; King Saud Medical City, Riyadh; and King Fahd Specialist Hospital, Dammam, Saudi Arabia, between March 2016 and  October 2018. The final follow up was in April 2019. The study measured patient understanding of prognosis, treatment options, and the level of the patient's anxiety.ResultsNinety-two patients were included in the analysis; 51 in the intervention group. A small proportion of both (DA with usual care and usual care) understood that mCRC was incurable (8% and 5%) of the 2 groups, respectively. There was no significant difference between groups in anxiety level; however, a time effect both initially and after one month was significantly higher than at 6 month.ConclusionThe study shows that a higher level of patient's baseline understanding lowered anxiety levels over time.  Decision aids group presented low levels of anxiety over time than those provided the usual care. We recommend  using Arabic DA in the oncology centers dealing with mCRC patients, aiming to empower patients in decision making.

13 keywords...

hide…